BOSTON, April 14, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Application (NDA) for ulixacaltamide HCl for the treatment of essential tremor (ET) in adults. The FDA has set […]
Focused ultrasound was approved as a treatment for essential tremor in 2016. It utilizes sound waves to target and burn tissue deep within the thalamus (in the middle part of the brain) to stop tremor. The thalamus is the relay station for motor and sensory signals. The patient has their head shaved and wears a […]
By Dr. Albert Fenoy,Director, Deep Brain Stimulation ProgramAssociate Professor, Department of NeurosurgeryMcGovern Medical SchoolThe University of Texas at Houston Patients with essential tremor (ET) usually present with hand tremor, an involuntary shaking of the hands dependent on position. However, head tremor can also develop in the course of ET or present as a singular symptom. […]
Clinical trials can be confusing. Amber Trzeciak, with Cadent Therapeutics, explains how they work and why they are important for the development of new drugs and treatments for medical conditions like essential tremor.
(This is an article from a past issue of Tremor Talk magazine. It’s just a sampling of the stories we include in this printed publication. Annual donors to the IETF receive Tremor Talk magazine in the mail three times per year.) By Arif Dalvi, MD, MBA Director of the Comprehensive Movement Disorders Program Palm Beach […]